Log in  First Connection?

Oncology ImagingArchives

Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?

 Published on 31/07/2026 |  Original article (Full-text)  | Valsamaki, Pipitsa N. et al. | Annals of Nuclear Medicine. Volume 40(8).

The introduction of prostate-specific membrane antigen-ligand positron emission tomography/computerised tomography (PSMA-ligand PET/CT) into clinical practice has altered the prevalence of non‑metastatic (by conventional imaging) castration-resistant prostate cancer (nmCRPC). We herewith briefly...